Receptor | Endogenous ligands | Exogenous ligands |
---|---|---|
Toll-like receptors | ||
TLR2 (PM)* | HMGB1 | Lipoteichoic acid, peptidoglycan (muramyl dipeptide) |
TLR3 (E) | Cellular dsRNA (e.g. U1 RNA) | Viral dsRNA, poly(I:C) |
TLR7 (E) | Cellular ssRNA (e.g. U1 RNA) | Bacterial ssRNA, viral ssRNA |
TLR9 (E) | Cellular dsDNA with unmethylated CpG sequences | Bacterial dsDNA with unmethylated CpG sequences |
NOD-like receptors | ||
NLRP3 (C) | Uric acid crystals†, cholesterol† | Muramyl dipeptide§, bacterial RNA§, poly(I:C)§, alum†, silica†, staphylococcal α-hemolysin†, influenza virus† |
AIM2 (C) | Cellular dsDNA | Bacterial dsDNA (e.g. vaccinia, Francisella) |
Location: PM, plasma membrane; E, endolysosome; C, cytoplasm
Acts via TLR and NFκB, which increases transcription of NLRP3 (“signal 1”)
Acts directly on NLRP3 via ATP and possibly decreased intracellular K+ or pore formation (“signal 2”)
Bold, involved in pristane-induced lupus